[EN] BENZO [B] ISOXAZOLOAZEPINE BROMODOMAIN INHIBITORS AND USES THEREOF [FR] INHIBITEURS DE BROMO-DOMAINE DE BENZO [B] ISOXAZOLOAZÉPINES ET APPLICATIONS ASSOCIÉES
SUBSTITUTED DIHYDROPYRAZOLONES FOR TREATING CARDIOVASCULAR AND HEMATOLOGICAL DISEASES
申请人:Thede Kai
公开号:US20100305085A1
公开(公告)日:2010-12-02
The invention relates to dihydropyrazolon-derivatives of formula (I), to methods for their production, to their use for treating and/or for preventing diseases and their use for producing medicaments for treating and/or for preventing diseases, in particular cardiovascular and haematological diseases, kidney diseases and for promoting the healing of wounds.
[EN] IODONIUM ANALOGS AS INHIBITORS OF NADPH OXIDASES AND OTHER FLAVIN DEHYDROGENASES; FORMULATIONS THEREOF; AND USES THEREOF<br/>[FR] ANALOGUES D'IODONIUM EN TANT QU'INHIBITEURS DE NADPH OXYDASES ET D'AUTRES FLAVINES DÉSHYDROGÉNASES, LEURS FORMULATIONS ET LEURS UTILISATIONS
申请人:US HEALTH
公开号:WO2015157145A1
公开(公告)日:2015-10-15
Disclosed herein are novel iodonium analogs having anticancer and anti-inflammatory activity.
本文披露了具有抗癌和抗炎活性的新型碘化物类似物。
Synthesis of Novel 5-Acetoacetyl-3-acetyl-2-pyridone Derivatives by the Ring-Transformation of 6-Methyl-1,3-oxazin-4-ones
The synthesis of novel poly-functionalized 5-acetoacetyl-3-acetyl-2-pyridone derivatives was achieved via the ring-transformation of 6-methyl-4H-1,3-oxazin-4-ones with 3-methylisoxazole derivatives, followed by reductive cleavage of the isoxazolering and hydrolysis.
The present invention relates to compounds useful as inhibitors of bromodomain-containing proteins. The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using said compositions in the treatment of various disorders.
BENZO [B] ISOXAZOLOAZEPINE BROMODOMAIN INHIBITORS AND USES THEREOF
申请人:Contellation Pharmaceuticals, Inc.
公开号:US20150148333A1
公开(公告)日:2015-05-28
The present invention relates to compounds useful as inhibitors of bromodomain-containing proteins. The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using said compositions in the treatment of various disorders.